Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 539627, 9 pages
http://dx.doi.org/10.1155/2015/539627
Research Article

Excessive Daytime Sleepiness Is Associated with Changes in Salivary Inflammatory Genes Transcripts

1Department of Anatomy and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA
2Department of Biological Sciences, Missouri University of Science and Technology, 400 W. 11th Street, Rolla, MO 65401, USA
3Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA
4Critical Care, Pulmonary and Sleep Associates, 274 Union Boulevard, Suite 110, Lakewood, CO 80228, USA

Received 22 September 2014; Revised 19 January 2015; Accepted 28 January 2015

Academic Editor: Jean Louis Pepin

Copyright © 2015 Matthew S. Thimgan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. P. A. van Dongen, G. Maislin, J. M. Mullington, and D. F. Dinges, “The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation,” Sleep, vol. 26, no. 2, pp. 117–126, 2003. View at Google Scholar · View at Scopus
  2. J. Lamphere, T. Roehrs, R. Wittig, F. Zorick, W. A. Conway, and T. Roth, “Recovery of alertness after CPAP in apnea,” Chest, vol. 96, no. 6, pp. 1364–1367, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. M. W. Johns, “A new method for measuring daytime sleepiness: the Epworth sleepiness scale,” Sleep, vol. 14, no. 6, pp. 540–545, 1991. View at Google Scholar · View at Scopus
  4. L. Ferini-Strambi, C. Baietto, M. R. di Gioia et al., “Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP),” Brain Research Bulletin, vol. 61, no. 1, pp. 87–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. K. Zammit, V. N. Joish, M. C. Kong, R. Balkrishnan, D. Lerner, and M. Rosekind, “Impact of nighttime awakenings on worker productivity and performance,” Journal of Occupational & Environmental Medicine, vol. 52, no. 5, pp. 513–518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Teran-Santos, A. Jimenez-Gomez, J. Cordero-Guevara, and Cooperative Group Burgos-Santander, “The association between sleep apnea and the risk of traffic accidents,” The New England Journal of Medicine, vol. 340, no. 11, pp. 847–851, 1999. View at Publisher · View at Google Scholar
  7. T. Young, L. Finn, P. E. Peppard et al., “Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort,” Sleep, vol. 31, no. 8, pp. 1071–1078, 2008. View at Google Scholar · View at Scopus
  8. A. M. Ingiosi, M. R. Opp, and J. M. Krueger, “Sleep and immune function: glial contributions and consequences of aging,” Current Opinion in Neurobiology, vol. 23, no. 5, pp. 806–811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Nadeem, J. Molnar, E. M. Madbouly et al., “Serum inflammatory markers in obstructive sleep apnea: a meta-analysis,” Journal of Clinical Sleep Medicine, vol. 9, pp. 1003–1012, 2013. View at Google Scholar
  10. J. K. Cremeans-Smith, K. Millington, E. Sledjeski, K. Greene, and D. L. Delahanty, “Sleep disruptions mediate the relationship between early postoperative pain and later functioning following total knee replacement surgery,” Journal of Behavioral Medicine, vol. 29, no. 2, pp. 215–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Vanninen, A. Tuunainen, M. Kansanen, M. Uusitupa, and E. Länsimies, “Cardiac sympathovagal balance during sleep apnea episodes,” Clinical Physiology, vol. 16, no. 3, pp. 209–216, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Tasali, R. Leproult, D. A. Ehrmann, and E. van Cauter, “Slow-wave sleep and the risk of type 2 diabetes in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 3, pp. 1044–1049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. W. Johns, A. Tucker, R. Chapman, K. Crowley, and N. Michael, “Monitoring eye and eyelid movements by infrared reflectance oculography to measure drowsiness in drivers,” Somnologie, vol. 11, no. 4, pp. 234–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tietäväinen, F. K. Gates, A. Meriläinen, J. E. Mandel, and E. Hæggström, “Nintendo Wii Fit based sleepiness tester detects impairment of postural steadiness due to 24 h of wakefulness,” Medical Engineering and Physics, vol. 35, no. 12, pp. 1850–1853, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Naidoo, “Potential of proteomics as a bioanalytic technique for quantifying sleepiness,” Journal of Clinical Sleep Medicine, vol. 7, no. 5, pp. S28–S30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Sánchez-de-la-Torre, A. Barceló, J. Piérola et al., “Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea,” Respiratory Medicine, vol. 105, no. 12, pp. 1954–1960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Nishino, B. Ripley, S. Overeem, G. J. Lammers, and E. Mignot, “Hypocretin (orexin) deficiency in human narcolepsy,” The Lancet, vol. 355, no. 9197, pp. 39–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Mignot, G. J. Lammers, B. Ripley et al., “The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias,” Archives of Neurology, vol. 59, no. 10, pp. 1553–1562, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Andlauer, H. Moore IV, S.-C. Hong et al., “Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy,” Sleep, vol. 35, no. 9, pp. 1247–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, “Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients,” Chest, vol. 122, no. 4, pp. 1162–1167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Seugnet, J. Boero, L. Gottschalk, S. P. Duntley, and P. J. Shaw, “Identification of a biomarker for sleep drive in flies and humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 52, pp. 19913–19918, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Seugnet, Y. Suzuki, M. Thimgan et al., “Identifying sleep regulatory genes using a Drosophila model of insomnia,” The Journal of Neuroscience, vol. 29, no. 22, pp. 7148–7157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. S. Thimgan, S. P. Duntley, and P. J. Shaw, “Changes in gene expression with sleep,” Journal of Clinical Sleep Medicine, vol. 7, no. 5, pp. S26–S27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Thimgan, L. Gottschalk, C. Toedebusch et al., “Cross-translational studies in human and Drosophila identify markers of sleep loss,” PLoS ONE, vol. 8, no. 4, Article ID e61016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Bachmann, F. Klaus, S. Bodenmann et al., “Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans,” Cerebral Cortex, vol. 22, no. 4, pp. 962–970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, A. Kales, K. Tyson, and G. P. Chrousos, “Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity,” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1313–1316, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Ohga, T. Tomita, H. Wada, H. Yamamoto, T. Nagase, and Y. Ouchi, “Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1,” Journal of Applied Physiology, vol. 94, no. 1, pp. 179–184, 2003. View at Google Scholar · View at Scopus
  28. M. A. Alzoghaibi and A. S. O. Bahammam, “Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study,” Sleep and Breathing, vol. 9, no. 3, pp. 119–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. U. Ciftci, O. Kokturk, N. Bukan, and A. Bilgihan, “The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome,” Cytokine, vol. 28, no. 2, pp. 87–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. L. M. O'Brien, R. Tauman, and D. Gozal, “Sleep pressure correlates of cognitive and behavioral morbidity in snoring children,” Sleep, vol. 27, no. 2, pp. 279–282, 2004. View at Google Scholar · View at Scopus
  31. A. Ursavaş, M. Karadaǧ, E. Rodoplu, A. Yilmaztepe, H. B. Oral, and R. O. Gözü, “Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome,” Respiration, vol. 74, no. 5, pp. 525–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Chin, T. Nakamura, K. Shimizu, M. Mishima, M. Miyasaka, and M. Ohi, “Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome,” American Journal of Medicine, vol. 109, no. 7, pp. 562–567, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. S. P. Duntley, A. H. Kim, D. L. Silbergeld, and J. W. Miller, “Characterization of the mu rhythm during rapid eye movement sleep,” Clinical Neurophysiology, vol. 112, no. 3, pp. 528–531, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society Series B: Methodological, vol. 57, no. 1, pp. 289–300, 1995. View at Google Scholar · View at MathSciNet
  36. E. F. Alf and J. M. Grossberg, “The geometric mean: confidence limits and significance tests,” Perception and Psychophysics, vol. 26, no. 5, pp. 419–421, 1979. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, “The occurrence of sleep-disordered breathing among middle-aged adults,” The New England Journal of Medicine, vol. 328, no. 17, pp. 1230–1235, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. D. M. Hiestand, P. Britz, M. Goldman, and B. Phillips, “Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll,” Chest, vol. 130, no. 3, pp. 780–786, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. K. J. Finkel, A. C. Searleman, H. Tymkew et al., “Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center,” Sleep Medicine, vol. 10, no. 7, pp. 753–758, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Rahaghi and R. C. Basner, “Delayed diagnosis of obstructive sleep apnea: don't ask, don't tell,” Sleep and Breathing, vol. 3, no. 4, pp. 119–124, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. P. E. Peppard, T. Young, M. Palta, J. Dempsey, and J. Skatrud, “Longitudinal study of moderate weight change and sleep-disordered breathing,” The Journal of the American Medical Association, vol. 284, no. 23, pp. 3015–3021, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. P. E. Peppard, T. Young, J. H. Barnet, M. Palta, E. W. Hagen, and K. M. Hla, “Increased prevalence of sleep-disordered breathing in adults,” The American Journal of Epidemiology, vol. 177, no. 9, pp. 1006–1014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. P. E. Peppard, T. Young, M. Palta, and J. Skatrud, “Prospective study of the association between sleep-disordered breathing and hypertension,” The New England Journal of Medicine, vol. 342, no. 19, pp. 1378–1384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Young, P. Peppard, M. Palta et al., “Population-based study of sleep-disordered breathing as a risk factor for hypertension,” Archives of Internal Medicine, vol. 157, no. 15, pp. 1746–1752, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Cheshire, H. Engleman, I. Deary, C. Shapiro, and N. J. Douglas, “Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome,” Archives of Internal Medicine, vol. 152, no. 3, pp. 538–541, 1992. View at Publisher · View at Google Scholar · View at Scopus
  46. M.-Á. Martínez-García, F. Capote, F. Campos-Rodríguez et al., “Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial,” The Journal of the American Medical Association, vol. 310, no. 22, pp. 2407–2415, 2013. View at Google Scholar · View at Scopus
  47. H. M. Engleman, K. E. Cheshire, I. J. Deary, and N. J. Douglas, “Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome,” Thorax, vol. 48, no. 9, pp. 911–914, 1993. View at Publisher · View at Google Scholar · View at Scopus
  48. G. E. Carpagnano, A. Spanevello, R. Sabato et al., “Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8,” Translational Research, vol. 155, no. 1, pp. 35–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. S. M. Shamsuzzaman, M. Winnicki, P. Lanfranchi et al., “Elevated C-reactive protein in patients with obstructive sleep apnea,” Circulation, vol. 105, no. 21, pp. 2462–2464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Yokoe, K. Minoguchi, H. Matsuo et al., “Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure,” Circulation, vol. 107, no. 8, pp. 1129–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Ohga, T. Nagase, T. Tomita et al., “Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome,” Journal of Applied Physiology, vol. 87, no. 1, pp. 10–14, 1999. View at Google Scholar · View at Scopus
  52. G. E. Carpagnano, A. Spanevello, R. Sabato, A. Depalo, V. Turchiarelli, and M. P. Foschino Barbaro, “Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome,” Translational Research, vol. 151, no. 1, pp. 45–50, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Gozal, S. Jortani, A. B. Snow et al., “Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 12, pp. 1253–1261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Redwine, R. L. Hauger, J. C. Gillin, and M. Irwin, “Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 10, pp. 3597–3603, 2000. View at Google Scholar · View at Scopus
  55. D. J. Frey, M. Fleshner, and K. P. Wright Jr., “The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults,” Brain, Behavior, and Immunity, vol. 21, no. 8, pp. 1050–1057, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Maret, S. Dorsaz, L. Gurcel et al., “Homer1a is a core brain molecular correlate of sleep loss,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 50, pp. 20090–20095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Ricciotti and G. A. Fitzgerald, “Prostaglandins and inflammation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 986–1000, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Dauvilliers, C. R. Baumann, B. Carlander et al., “CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, no. 12, pp. 1667–1673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Wennström, E. Londos, L. Minthon, and H. M. Nielsen, “Altered CSF orexin and alpha-synuclein levels in dementia patients,” Journal of Alzheimer's Disease, vol. 29, no. 1, pp. 125–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Fronczek, S. van Geest, M. Frölich et al., “Hypocretin (orexin) loss in Alzheimer's disease,” Neurobiology of Aging, vol. 33, no. 8, pp. 1642–1650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Lopez, L. Barateau, S. Chenini, and Y. Dauvilliers, “Preliminary results on CSF biomarkers for hypothalamic dysfunction in Kleine-Levin syndrome,” Sleep Medicine, vol. 16, no. 1, pp. 194–196, 2015. View at Publisher · View at Google Scholar